Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Om Anand

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
AAPS Pharmscitech|January 20, 2012
Controlled release of modified insulin glargine from novel biodegradable injectable gelsOm Anand, Hassan Almoazen, Nitin Mehrotra, et al.
Pharmaceutical Research|May 18, 2022
The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry PerspectivesOm Anand, Xavier J H Pepin, Vidula Kolhatkar, et al.
The AAPS Journal|April 12, 2011
Dissolution testing for generic drugs: an FDA perspectiveOm Anand, Lawrence X Yu, Dale P Conner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 25, 2025
Development of in vitro-in vivo correlation for establishing patient-centric quality standards of dissolution for lamotrigine extended-release tabletsAhmed Zidan, Abu Bakar Siddique, Maha Shaklah, et al.
The AAPS Journal|October 27, 2021
Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) DrugsMin Li, Xinwen Zhang, Di Wu, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
The AAPS Journal|September 8, 2017
In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube AdministrationPing Ren, Minglei Cui, Om Anand, et al.
The AAPS Journal|March 30, 2022
Current Approaches for Dissolution Similarity Assessment, Requirements, and Global ExpectationsAndreas M Abend, Limin Zhang, Emilija Fredro-Kumbaradzi, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
Journal of Pharmaceutical Sciences|November 5, 2020
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary ReportAmitava Mitra, Sandra Suarez-Sharp, Xavier J H Pepin, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
AAPS Pharmscitech|January 20, 2012
Controlled release of modified insulin glargine from novel biodegradable injectable gelsOm Anand, Hassan Almoazen, Nitin Mehrotra, et al.
Pharmaceutical Research|May 18, 2022
The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry PerspectivesOm Anand, Xavier J H Pepin, Vidula Kolhatkar, et al.
The AAPS Journal|April 12, 2011
Dissolution testing for generic drugs: an FDA perspectiveOm Anand, Lawrence X Yu, Dale P Conner, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|September 25, 2025
Development of in vitro-in vivo correlation for establishing patient-centric quality standards of dissolution for lamotrigine extended-release tabletsAhmed Zidan, Abu Bakar Siddique, Maha Shaklah, et al.
The AAPS Journal|October 27, 2021
Understanding In Vivo Dissolution of Immediate Release (IR) Solid Oral Drug Products Containing Weak Acid BCS Class 2 (BCS Class 2a) DrugsMin Li, Xinwen Zhang, Di Wu, et al.
The AAPS Journal|June 22, 2012
Statistics on BCS classification of generic drug products approved between 2000 and 2011 in the USAAnil K Nair, Om Anand, Nam Chun, et al.
The AAPS Journal|September 8, 2017
In vitro Approaches to Support Bioequivalence and Substitutability of Generic Proton Pump Inhibitors via Nasogastric Tube AdministrationPing Ren, Minglei Cui, Om Anand, et al.
The AAPS Journal|March 30, 2022
Current Approaches for Dissolution Similarity Assessment, Requirements, and Global ExpectationsAndreas M Abend, Limin Zhang, Emilija Fredro-Kumbaradzi, et al.
Pharmaceutics|May 28, 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar SeriesMark McAllister, Talia Flanagan, Susan Cole, et al.
Journal of Pharmaceutical Sciences|November 5, 2020
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary ReportAmitava Mitra, Sandra Suarez-Sharp, Xavier J H Pepin, et al.
Pageof 1